Discontinuation of first-line disease-modifying therapy in relapse onset multiple sclerosis.

E M E Coerver, A Bourass, M H J Wessels,Z L E van Kempen, M M S Jasperse, B A R Tonino,F Barkhof,J Mostert,B M J Uitdehaag,J Killestein,E M M Strijbis

Multiple sclerosis and related disorders（2023）

引用 1|浏览8

暂无评分

摘要

Higher age at first-line DMT discontinuation is associated with lower risk and severity of radiological disease activity in MS, and a lower risk of relapse(s) after discontinuation.

查看译文

关键词

multiple sclerosis,relapse onset,first-line,disease-modifying

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要